Amplitude's Q3 Surge: 25% Revenue Growth and Raised Guidance Signal Enterprise Momentum

What happened

Amplitude reported third-quarter 2026 revenue of $111 million, up 25% from a year earlier, and raised its full-year outlook, citing stronger enterprise adoption of its analytics and experimentation products. This marks a significant acceleration from the 18% revenue growth recorded in the same quarter last year and exceeds the mid-teens growth assumed in the prior base case. The raised guidance indicates management expects the momentum to continue, but the company has not yet disclosed key metrics such as dollar-based net retention or non-GAAP operating margin for the quarter. While the GAAP losses likely remain substantial, the improved top-line trajectory may lead to better operating leverage if fixed costs are managed effectively. The results align with the bull scenario from the previous analysis, which anticipated ARR growth above 18% and NRR above 108%, but confirmation of profitability improvements is necessary to underwrite a higher valuation.

Implication

The 25% revenue growth and raised guidance directly contradict the bear case of competitive displacement and support a re-rating toward the bull scenario's $14 implied value if sustained. However, the stock's current valuation at ~3.1x forward sales already embeds a moderate growth premium, so upside from here depends on continued acceleration and margin expansion beyond breakeven. Key risks include the heavy AI-related spending that may keep GAAP losses elevated, potential competition from AI platform vendors, and the possibility that the revenue acceleration was driven by one-time enterprise deals rather than broad-based adoption. Investors should closely monitor the next quarterly print for NRR above 105%, non-GAAP operating margin in the low single digits, and evidence that AI features are contributing to incremental ARR. Until those confirmations occur, the stock remains a high-risk, high-reward proposition suitable for small positions with a 6-12 month horizon.

Thesis delta

The thesis shifts from a potential buy with a base-case assumption of 13-16% ARR growth to a more constructive outlook as Q3 revenue accelerated to 25% and full-year guidance was raised. This increases the probability of the bull case, which implied fair value near $14. However, the lack of disclosed NRR and margin data means the shift is tentative pending confirmation that growth is durable and non-GAAP profitability remains at least breakeven.